Epoch Pharmacuticals Profile
Key Indicators
- Authorised Capital ₹ 1.60 M
as on 04-12-2024
- Paid Up Capital ₹ 1.51 M
as on 04-12-2024
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 3.06 Cr
as on 04-12-2024
- Satisfied Charges ₹ 1.00 Cr
as on 04-12-2024
About Epoch Pharmacuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 1.60 M and a paid-up capital of Rs 1.51 M.
The company currently has active open charges totaling ₹3.06 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vinay Tripathi, Pitambara Tiwary, Ashutosh Tripathi, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397GJ2003PTC042563
- Company No.
042563
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2003
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Epoch Pharmacuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Tripathi  | Director | 01-Feb-2012 | Current |
| Pitambara Tiwary | Director | 01-Feb-2012 | Current |
| Ashutosh Tripathi | Director | 20-Oct-2018 | Current |
| Pranav Tripathi | Director | 20-Oct-2018 | Current |
Financial Performance of Epoch Pharmacuticals.
Enhance accessibility to Epoch Pharmacuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Epoch Pharmacuticals?
Unlock access to Epoch Pharmacuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 20 Sep 2012 | ₹3.06 Cr | Open |
Indusind Bank Ltd. Creation Date: 24 Apr 2011 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Epoch Pharmacuticals?
Unlock and access historical data on people associated with Epoch Pharmacuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Epoch Pharmacuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epoch Pharmacuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
